Anticancer Drug Candidate CBL0137, Which Inhibits Chapterone FACT, Is Efficacious in Preclinical Orthotopic Models of Temozolomide-Responsive and -Resistant Glioblastoma

Barone TA, Burkhart CA, Safina A, Haderski G, Gurova KV, Purmal AA, Gudkov AV, Plunkett RJ: Anticancer Drug Candidate CBL0137, Which Inhibits Chapterone FACT, Is Efficacious in Preclinical Orthotopic Models of Temozolomide-Responsive and -Resistant Glioblastoma. Neuro Oncol 19:186-196, February 2017 (epub July 1, 2016 DOI 10.1093/neuonc/now141). PMID 27370399

Please notify our office immediately if you have a fever, cough, runny nose, or shortness of breath or have been in contact with someone who has been diagnosed with COVID-19. UBNS is following all CDC and New York State Dept. of Health guidelines for preventing the spread of COVID-19. Due to increased call volume, hold times are longer than usual. We apologize for the inconvenience.